Applying cefepime population pharmacokinetics on critically ill patients receiving continuous renal replacement therapy,Antimicrobial Agents and Chemotherapy

当前位置： X-MOL 学术 › Antimicrob. Agents Chemother. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Applying cefepime population pharmacokinetics on critically ill patients receiving continuous renal replacement therapy
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-10-18 , DOI: 10.1128/aac.01611-21
Mohammad H Al-Shaer _{1,

2} , Kelly Maguigan ₃ , Jennifer Ashton ₃ , Veena Venugopalan ₂ , Molly E Droege _{4,

5} , Carolyn D Philpott _{4,

5} , Christopher A Droege _{4,

5} , Daniel P Healy ₅ , Eric W Mueller _{4,

5} , Charles A Peloquin _{1,

2}

Affiliation

Patients admitted to the intensive care unit (ICU) may need continuous renal replacement therapy (CRRT) due to acute kidney injury or worsening of underlying chronic kidney disease. This will affect their antimicrobial exposure and may have a significant ...

中文翻译：